MicroRNA-124 links p53 to the NF-κB pathway in B-cell lymphomas

Hepatocyte nuclear factor 4α-nuclear factor-κB feedback circuit modulates liver cancer progression

(2014) Bei-Fang Ning et al.   HEPATOLOGY

A microRNA-mediated regulatory loop modulates NOTCH and MYC oncogenic signals in B- and T-cell malignancies

(2014) M Ortega et al.   LEUKEMIA

microRNA-124 inhibits proliferation and induces apoptosis by directly repressing EZH2 in gastric cancer

(2014) Liming Xie et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

MicroRNA-124 suppresses growth of human hepatocellular carcinoma by targeting STAT3

(2013) Yanxin Lu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification

(2013) G. Ott et al.   BLOOD

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

(2013) S. Hu et al.   BLOOD

Multifunctional roles of urokinase plasminogen activator (uPA) in cancer stemness and chemoresistance of pancreatic cancer

(2013) Swapna Asuthkar et al.   MOLECULAR BIOLOGY OF THE CELL

microRNA-124 Inhibits Migration and Invasion by Down-Regulating ROCK1 in Glioma

(2013) Liwen An et al.   PLoS One

MiR-124 Suppresses Growth of Human Colorectal Cancer by Inhibiting STAT3

(2013) Jufeng Zhang et al.   PLoS One

MicroRNA-124–Mediated Regulation of Inhibitory Member of Apoptosis-Stimulating Protein of p53 Family in Experimental Stroke

(2013) Xiangrong Liu et al.   STROKE

The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomas

(2012) L. Di Lisio et al.   BLOOD

Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

(2012) Tina Marie Green et al.   JOURNAL OF CLINICAL ONCOLOGY

Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

(2012) Nathalie A. Johnson et al.   JOURNAL OF CLINICAL ONCOLOGY

MicroRNAs miR-125a and miR-125b constitutively activate the NF- B pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20)

(2012) S.-W. Kim et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The p53 network: cellular and systemic DNA damage responses in aging and cancer

(2012) H. Christian Reinhardt et al.   TRENDS IN GENETICS

Gene Set Enrichment Analysis Unveils the Mechanism for the Phosphodiesterase 4B Control of Glucocorticoid Response in B-cell Lymphoma

(2011) S.-W. Kim et al.   CLINICAL CANCER RESEARCH

Epigenetic Inactivation of the miR-124-1 in Haematological Malignancies

(2011) Kwan Yeung Wong et al.   PLoS One

Novel therapeutic agents for B-cell lymphoma: developing rational combinations

(2010) C. B. Reeder et al.   BLOOD

Double-hit B-cell lymphomas

(2010) S. M. Aukema et al.   BLOOD

Aggressive Lymphomas

(2010) Georg Lenz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Copy number abnormalities, MYC activity, and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of diffuse large B-cell lymphoma

(2009) C. Li et al.   BLOOD

Rational combined targeting of phosphodiesterase 4B and SYK in DLBCL

(2009) S.-W. Kim et al.   BLOOD